000155630 001__ 155630
000155630 005__ 20221128161131.0
000155630 0247_ $$2doi$$a10.1080/10428194.2021.1889537
000155630 0247_ $$2pmid$$apmid:33612072
000155630 0247_ $$2ISSN$$a1026-8022
000155630 0247_ $$2ISSN$$a1029-2403
000155630 0247_ $$2ISSN$$a1042-8194
000155630 037__ $$aDZNE-2021-00798
000155630 041__ $$aEnglish
000155630 082__ $$a610
000155630 1001_ $$00000-0001-6434-0950$$aBittner, Aitomi$$b0$$eCorresponding author
000155630 245__ $$aCerebral EBV-positive PTLD controlled by PD-1 checkpoint blockade in a liver transplant patient.
000155630 260__ $$aLondon [u.a.]$$bTaylor & Francis Group$$c2021
000155630 3367_ $$2DRIVER$$aarticle
000155630 3367_ $$2DataCite$$aOutput Types/Journal article
000155630 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1630483548_17166$$xLetter
000155630 3367_ $$2BibTeX$$aARTICLE
000155630 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000155630 3367_ $$00$$2EndNote$$aJournal Article
000155630 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000155630 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000155630 650_7 $$2NLM Chemicals$$aProgrammed Cell Death 1 Receptor
000155630 650_2 $$2MeSH$$aEpstein-Barr Virus Infections: complications
000155630 650_2 $$2MeSH$$aHerpesvirus 4, Human
000155630 650_2 $$2MeSH$$aHumans
000155630 650_2 $$2MeSH$$aLiver Transplantation
000155630 650_2 $$2MeSH$$aLymphoproliferative Disorders: diagnosis
000155630 650_2 $$2MeSH$$aLymphoproliferative Disorders: etiology
000155630 650_2 $$2MeSH$$aProgrammed Cell Death 1 Receptor: antagonists & inhibitors
000155630 650_2 $$2MeSH$$aViral Load
000155630 7001_ $$aRadke, Josefine$$b1
000155630 7001_ $$aEurich, Dennis$$b2
000155630 7001_ $$aWiener, Edzard$$b3
000155630 7001_ $$aDenker, Sophy$$b4
000155630 7001_ $$aAnagnostopoulos, Ioannis$$b5
000155630 7001_ $$aNa, Il-Kang$$b6
000155630 7001_ $$0P:(DE-2719)2812386$$aHeppner, Frank L$$b7$$udzne
000155630 7001_ $$aBullinger, Lars$$b8
000155630 7001_ $$aSchmitt, Clemens A$$b9
000155630 773__ $$0PERI:(DE-600)2030637-4$$a10.1080/10428194.2021.1889537$$gVol. 62, no. 8, p. 2026 - 2029$$n8$$p2026 - 2029$$tLeukemia and lymphoma$$v62$$x1029-2403$$y2021
000155630 909CO $$ooai:pub.dzne.de:155630$$pVDB
000155630 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812386$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b7$$kDZNE
000155630 9130_ $$0G:(DE-HGF)POF3-341$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vMolecular Signaling$$x0
000155630 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000155630 9141_ $$y2021
000155630 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2021-02-02$$wger
000155630 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLEUKEMIA LYMPHOMA : 2019$$d2021-02-02
000155630 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-02-02
000155630 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-02-02
000155630 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-02-02
000155630 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-02-02
000155630 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-02-02
000155630 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-02-02
000155630 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-02
000155630 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-02-02
000155630 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-02
000155630 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-02-02
000155630 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-02-02
000155630 9201_ $$0I:(DE-2719)1810007$$kAG Heppner$$lNeuroimmunology$$x0
000155630 980__ $$ajournal
000155630 980__ $$aVDB
000155630 980__ $$aI:(DE-2719)1810007
000155630 980__ $$aUNRESTRICTED